Patent · US Active

Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis

US12102637B2 · kind B2 · utility

0Cited by

16References

16Claims

0Family size

Assignees

Abb Vie Inc. · US
Neurocrine Biosciences, Inc. · US

Inventors

Jayanthy Jayanth · Buffalo Grove, US
Kevin C. Spence · Vernon Hills, US
Gregory A. McClelland · Lawrence, US
Anna V. Stepanenko · Del Mar, US
Tzuchi R. Ju · North Chicago, US
Xi Shao · Lake Bluff, US

Key dates

Filing date	Feb 13, 2023
Grant date	Oct 1, 2024
Priority date	—
Expiry date	Feb 13, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P15/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.